News

Archive by tag: LeukemiaReturn

09

Personalized cell therapy combination achieves complete remission in CLL patients

posted on 6/9/2017 1:27:00 PM

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research.